Product photo 1 of 1

Cagrilintide

Cagrilintide (AM833) is a synthetic, lipidated 37-amino-acid amylin analogue with an intramolecular disulfide bridge, characterized as a non-selective amylin and calcitonin receptor agonist. Supplied as a lyophilized research reference material with lot-specific, independently tested documentation.

$128.00

Out of stock

Cagrilintide—
$128.00

For research use only. Not for human or veterinary use.

Chemical information

Vial content
5 mg per vial
Compound
Cagrilintide
Also known as
AM833, NN0174-0833
Classification
Synthetic lipidated amylin analogue; amylin and calcitonin receptor agonist
Sequence
(C20 diacid–γGlu)-KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH₂ (disulfide Cys2–Cys7)
Length
37 amino acids
Molecular formula
C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular weight
4409.0 g/mol
CAS number
1415456-99-3
PubChem CID
171397054
Form
Lyophilized (freeze-dried) powder
Storage
Store lyophilized at −20 °C, sealed and protected from light and moisture. Allow the vial to reach room temperature before opening.

Chemical information is for identification and reference. Formula and weight are for the free peptide or compound; the supplied salt form (e.g. acetate) may differ. The lot's certificate of analysis is the reference for the material you receive.

Testing & documentation

Every lot is tested independently by Finnrick before release for identity, purity, quantity, endotoxins and heavy metals. The current lot's certificate of analysis is linked above, and any lot number can be checked on the COA & lot lookup page.

How we test every lot

Shipping & sales policy

Ships by USPS Ground Advantage or Priority Mail to street addresses in the 50 states and DC. No PO boxes, military or territory addresses.

All sales are final. If an item arrives wrong or damaged, or your package is lost, report it from your account within 7 days and we'll reship or refund.

Research use only

For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes. See our research-use policy.